Adagene Competitors and Similar CompaniesClear all
APEIRON Biologics's competitors and similar companies include Tetherex, UT Health San Antonio MD Anderson Cancer Center and Fuse Biotherapeutics.
 APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. |  Tetherex Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases. |  UT Health San Antonio MD Anderson Cancer Center UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care. | ||
Founding Date | Founding Date 2005 | Founding Date 2014 | Founding Date N/A | Founding Date 2021 |
Type | Type Private | Type Private | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Wien, AT HQ | Locations Oklahoma City, US HQ Morrisville, US | Locations San Antonio, US HQ | Locations Woburn, US HQ |
Employees | Employees 8 | Employees N/A | Employees N/A | Employees 5 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 43m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 9.5m (almost 3 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 46.2m | Total funding raised N/A | Total funding raised $ 9.5m |
For sources of this data, please see the company profile
View Company Profiles
Tetherex
HQ
Oklahoma City, US
Tetherex Pharmaceuticals Corp is a biopharmaceutical company focused on development of therapeutics for the treatment of inflammation, thrombosis and tumor metastasis across a broad range of severe diseases.
View companyUT Health San Antonio MD Anderson Cancer Center
HQ
San Antonio, US
UT Health San Antonio MD Anderson Cancer Center is an institution that researches cancer and provides patients care.
View company
Fuse Biotherapeutics
HQ
Woburn, US
Employees
5
Fuse Biotherapeutics is a developer of immunotherapies for cancer patients.
View company